Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Due to the poor prognosis of advanced metastatic melanoma, it is crucial to find early biomarkers that help identify which melanomas will metastasize. By comparing the gene expression data from primary and cutaneous melanoma samples from The Cancer Genome Atlas (TCGA), we identified GPC6 among a set of genes whose expression levels can distinguish...
Alternative Titles
Full title
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2240300774
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2240300774
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0218067
